MetaCap

Immunocore Statistics

NASDAQ: IMCRHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

26.41-0.22 (-0.83%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Immunocore by the numbers

Immunocore has a market capitalization of $1.36 billion based on 51.68M shares outstanding. With trailing EPS of $-0.64, Immunocore is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 13.0% below its 50-day average and 16.1% below its 200-day average.

Average daily trading volume is 450.88K shares, or about $11.9 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

IMCR valuation vs. peer median

IMCR compared with the median of 8 peer companies
MetricIMCRPeer medianDifference
Market cap$1.36B$1.43B-5%
Avg. volume450.88K1.79M-75%

Peer median across 8 companies: MESO, WWB, ALVO, NVAX, RXRX, TSHA, VIR, VOR.

Valuation

Price / sales (latest FY)
3.41
EPS (TTM)
$-0.64

Price and trading

Previous close
26.63
Open
26.37
Day range
25.61 – 26.77
52-week range
25.61 – 40.72
52-week change
-32.88%
Beta
—
Volume
546.18K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
1.36B
Forward Pe
-41.10
Eps
-0.64
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
40.72
Week52 Low
25.61
Avg Volume
450.88K
Shares Outstanding
51.68M
Ma50
30.37
Ma200
31.47
Earnings Date
Nov 6, 2026
Pct From52w High
-35.13%
Pct From52w Low
3.11%

Related